Keros Therapeutics (KROS) Announces Review of Strategic Alternatives

Go back to Keros Therapeutics (KROS) Announces Review of Strategic Alternatives
(NASDAQ: KROS) Delayed: 11.20 +0.03 (0.27%)
Previous Close $11.17    52 Week High
Open $11.25    52 Week Low
Day High $11.34    P/E N/A 
Day Low $11.17    EPS
Volume 8,591